By attending this webinar you will:
- Gain practical insights into modernizing CE-SDS workflows to improve laboratory productivity, increase throughput, and support growing analytical demands.
- Learn real-world considerations for method transfer and platform adoption.
- Discover how advanced detection approaches such as native fluorescence detection can enhance sensitivity and streamline AAV characterization workflow.
Event Overview
CE-SDS (capillary electrophoresis-sodium dodecyl sulfate) remains a cornerstone technique for biotherapeutic characterization. Today's laboratories require greater throughput, flexibility, and analytical performance. Join our industry expert as he shares real-world experiences implementing next-generation CE-SDS workflows. Explore lessons learned from transitioning established methods to a multi-capillary platform and discover how native fluorescence detection is enhancing AAV capsid protein analysis with improved sensitivity, streamlined workflows, and label-free detection.
- Scale CE-SDS throughput with automation and parallel analysis.
- Streamline CE-SDS method transfer to next-generation platforms.
- Enhance AAV method development with label-free native fluorescence detection.
What you need to know
Date: 19 November, 2026
Start time:
9 am PST (Los Angeles) / 11 am CST (Chicago) / 12 pm EST (New York) / 5 pm GMT (London/Lisbon)
Who should attend
Scientists, lab managers, and technology decision makers who want to increase CE-SDS throughput, streamline method transfer, and apply new detection technologies to support evolving biopharmaceutical modalities.


